JTR  Vol.5 No.4 , December 2017
Anemia and Hematologic Characteristics in Newly Diagnosed Pulmonary Tuberculosis Patients at Diagnosis in Kinshasa
Abstract: Context: The burden of TB in Africa tends to be exacerbated by the socio-economic situation and the high prevalence of intercurrent infections such as HIV, malaria and non-specific bacterial infections. These factors often result in anemia, making patients at high risk for anemia. Objective: We aimed to gain insights into the characteristics of anemia, hematologic variations and socio-economic status in untreated pulmonary TB patients (PTB) in Kinshasa, the Democratic Republic of Congo. Methods: We conducted a cross-sectional analysis of 200 smear-positive pulmonary TB patients (PTB) recruited at the initiation of TB treatment. Complete Blood Count, Iron profile, BMI, CRP and albuminemia were assessed. Data were analyzed using Student t or Mann Whitney tests as appropriate, and logistic regression was performed to assess the strength of associations. Results: Anemia was a regular finding in (69%). This anemia was mostly moderate (92.2%) and with iron deficiency pattern (48%). Hypoalbuminemia was observed in half of the subjects and appears to be correlated with the severity of anemia. Surprisingly, the severity of inflammation, as reflected by the CRP, was inversely correlated with the anemia. In the multivariate analysis, alcohol intake (OR: 2.38; IC 95%: 1.05 - 5.38), hypoalbuminemia (OR: 1.98; IC 95%: 1.02 - 3.82) and CRP rate were significantly associated with the presence of anemia among pulmonary tuberculosis at the diagnostic. Conclusion: This study demonstrates the heavy burden of the iron responsive anemia and risky life conditions in newly diagnosed TB patients, and underscores the potential usefulness of iron supplementation in the Congolese context.
Cite this paper: Mulenga, C. , Kayembe, J. , Kabengele, B. and Bakebe, A. (2017) Anemia and Hematologic Characteristics in Newly Diagnosed Pulmonary Tuberculosis Patients at Diagnosis in Kinshasa. Journal of Tuberculosis Research, 5, 243-257. doi: 10.4236/jtr.2017.54026.

[1]   World Health Organization (2016) Global Tuberculosis Report 2016. WHO Library Cataloguing-in-Publication Data.

[2]   Droz, N., De Lauzanne, A., Holvoet, L., Missud, F., Benkerrou, M., Brousse, V., Odièvre, M.H., Faye, A. and Koehl, B. (2017) Tuberculosis in Children with Sickle Cell Anaemia: A Retrospective Study in French Tertiary Care Centres. European Journal of Pediatrics, 176, 723-729.

[3]   Ahmed, S.G., Bukar, A.A. and Jolayemi, B. (2010) Hematological Indices of Sickle Cell Anaemia Patients with Pulmonary Tuberculosis in Northern Nigeria. Mediterranean Journal of Hematology and Infectious Diseases, 2, e2010014.

[4]   Minchella, P.A., Donkor, S., Owolabi, O., Sutherland, J.S. and McDermid, J.M. (2015) Complex Anemia in Tuberculosis: The Need to Consider Causes and Timing When Designing Interventions. Clinical Infectious Diseases, 60, 764-772.

[5]   Lee, S.W., Kang, Y.A., Yoon, Y.S., Um, S.W., Lee, S.M., Yoo, C.G., Kim, Y.W., Han, S.K., Shim, Y.S. and Yim, J.J. (2006) The Prevalence and Evolution of Anemia Associated with Tuberculosis. Journal of Korean Medical Science, 21, 1028-1032.

[6]   Banerjee, M., Chaudhary, B.L. and Shukla, S. (2015) Hematological Profile among Pulmonary Tuberculosis Patients in Tertiary Care Hospital. International Journal of Bioassays, 4, 3900-3902.

[7]   Atomsa, D., Abebe, G. and Sewunet, T. (2014) Immunological Markers and Hematological Parameters among Newly Diagnosed Tuberculosis Patients at Jimma University Specialized Hospital. Ethiopian Journal of Health Sciences, 24, 311-318.

[8]   Kassebaum, N.J., Jasrasaria, R., Naghavi, M., Wulf, S.K., Johns, N., Lozano, R., Regan, M., Weatherall, D., Chou, D.P., Eisele, T.P., Flaxman, S.R., Pullan, R.L., Brooker, S.J. and Murray, C.J. (2014) A Systematic Analysis of Global Anemia Burden from 1990 to 2010. Blood, 123, 615-624.

[9]   Sahiratmadja, E., Wieringa, F.T., van Crevel, R., de Visser, A.W., Adnan, I., Alisjahbana, B., Slagboom, E., Marzuki, S., Ottenhoff, T.H., van de Vosse, E. and Marx, J.J. (2007) Iron Deficiency and NRAMP1 Polymorphisms (INT4, D543N and 3'UTR) Do Not Contribute to Severity of Anaemia in Tuberculosis in the Indonesian Population. British Journal of Nutrition, 98, 684-690.

[10]   Kerkhoff, A.D., Wood, R., Cobelens, F.G., Gupta-Wright, A., Bekker, L.G. and Lawn, S.D. (2014) Resolution of Anaemia in a Cohort of HIV-Infected Patients with a High Prevalence and Incidence of Tuberculosis Receiving Antiretroviral Therapy in South Africa. BMC Infectious Diseases, 14, 3860.

[11]   Devi, U., Rao, C.M., Srivastava, V.K., Rath, P.K. and Das, B.S. (2003) Effect of Iron Supplementation on Mild to Moderate Anaemia in pulmonary Tuberculosis. The British Journal of Nutrition, 90, 541-550.

[12]   Weiss, G. (2002) Pathogenesis and Treatment of Anaemia of Chronic Disease. Blood Reviews, 16, 87-96.

[13]   Borgdorff, M.W., Veen, J., Kalisvaart, N.A. and Nagelkerke, N. (1998) Mortality among Tuberculosis Patients in the Netherlands in the Period 1993-1995. European Respiratory Society, 11, 816-820.

[14]   Waitt, C.J. and Squire, S.B. (2011) Une revue systématique des facteurs de risque de décès chez les adultes pendant et après le traitement de la tuberculose. [A Systematic Review of Risk Factors for Death in Adults during and after Tuberculosis Treatment (Review Article).] International Journal of Tuberculosis and Lung Disease, 15, 871-885.

[15]   Matos, E.D. and Moreira Lemos, A.C. (2006) Association between Serum Albumin Levels and In-Hospital Deaths Due to Tuberculosis. International Journal of Tuberculosis and Lung Disease, 10, 1360-1366.

[16]   Garcic, A. (1979) A Highly Sensitive, Simple Determination of Serum Iron Using Chromazurol B. Clinica Chimica Acta, 94, 115-119.

[17]   Doumas, B.T., Watson, W.A. and Biggs, H.G. (1997) Albumin Standards and the Measurement of Serum Albumin with Bromcresol Green. Clinica Chimica Acta, 258, 21-30.

[18]   Delanaye, P., Cavalier, E., Maillard, N., Krzesinski, J.M., Mariat, C., Cristol, J.P. and Piéroni, L. (2010) Creatinine: Past and Present. Annales De Biologie Clinique (Paris), 68, 531-543.

[19]   Ministry of Planification, Ministry of Health and ICF International (2014) Demographic and Health Survey in DR Congo 2013-2014. MPSMRM, MSP et ICF International, Rockville, Maryland.

[20]   World Health Organization (2017) BMI Classification. World Health Organization, Geneva.

[21]   World Health Organization (2008) WHO and the CDC Worldwide Prevalence of Anemia 1993-2005: Who Global Database on Anemia. World Health Organization, Geneva.

[22]   World Health Organisation (2011) Hemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. World Health Organization, Geneva.

[23]   Weiss, G. and Goodnough, L.T. (2005) Anemia of Chronic Disease. The New England Journal of Medicine, 35, 1011-1023.

[24]   Hane, A.A., Thiam, D., Cissokho, S., Kabou, F., Ndiaye, M., Diop, S., Ba, O., Fall, K., Diop, B.M., Ndir, M., Diedhiou, A., Tou-ré-Fall, A.O. and Diakhate, L. (1999) Hematologic Abnormalities and Immunodepression in HIV/AIDS-Related Pulmonary Tuberculosis. Bulletin De La Societe De Pathologie Exotique, 92, 161-163.

[25]   Unsal, E., Aksaray, S., Köksal, D. and Sipit, T. (2005) Potential Role of Interleukin 6 in Reactive Thrombocytosis and Acute Phase Response in Pulmonary Tuberculosis. Postgraduate Medical Journal, 81, 604-607.

[26]   Oliva, V.M., Cezário, G.A.G., Cocato, R.A. and Marcondes-Machado J. (2008) Pulmonary Tuberculosis: Hematology, Serum Biochemistry and the Relation with the Disease Duration. Journal of Venomous Animals and Toxins Including Tropical Diseases, 14, 71-81.

[27]   Blanc, F.-X. (2011) Tuberculose: Le réveil d’une belle endormie. [Tuberculosis: Waking up from a Deep.] Revue des Maladies Respiratoires Actualités, 3, 532-537.

[28]   Pelissari, D.M. and Diaz-Quijano, F.A. (2017) Household Crowding as a Potential Mediator of Socioeconomic Determinants of Tuberculosis Incidence in Brazil. PLoS ONE, 12, e0176116.

[29]   Abebe, F., Belay, M., Legesse, M., Mihret, A. and Franken, K.S. (2017) Association of ESAT-6/CFP-10-Induced IFN-γ, TNF-α and IL-10 with Clinical Tuberculosis: Evidence from Cohorts of Pulmonary Tuberculosis Patients, Household Contacts and Community Controls in an Endemic Setting. Clinical & Experimental Immunology, 189, 241-249.

[30]   Kellar, K.L., Gehrke, J., Weis, S.E., Mahmutovic-Mayhew, A., Davila, B., Zajdowicz, M.J., Scarborough, R., LoBue, P.A., Lardizabal, A.A., Daley, C.L., Reves, R.R., Bernardo, J., Campbell, B.H., Whitworth, W.C. and Mazurek, G.H. (2011) Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens. PLoS One, 6, e26545.

[31]   Nyamogoba, H.D., Mbuthia, G., Mining, S., Kikuvi, G., Biegon, R., Mpoke, S., Menya, D. and Waiyaki, P.G. (2012) HIV Co-Infection with Tuberculous and Non-Tuberculous Mycobacteria in Western Kenya: Challenges in the Diagnosis and Management. African Health Sciences, 12, 305-311.

[32]   Saranchuk, P., Boulle, A., Hilderbrand, K., Coetzee, D., Bedelu, M., van Cutsem, G. and Meintjes, G. (2007) Evaluation of a Diagnostic Algorithm for Smear-Negative Pulmonary Tuberculosis in HIV-Infected Adults. South African Medical Journal, 97, 517-523.

[33]   Abaye, G.E., Abebe, T., Worku, A., Tolessa, D., Ameni, G. and Mihret, A. (2017) Detection of Mycobacterium tuberculosis from the Stool of HIV Sero-Positive Individuals Suspected of Pulmonary Tuberculosis. PLoS One, 12, e0177529.

[34]   Padmapriyadarsini, C., Tripathy, S., Sekar, L., Bhavani, P.K., Gaikwad, N., Annadurai, S., Narendran, G., Selvakumar, N., Risbud, A.R., Sheta, D., Rajasekaran, S., Thomas, A., Wares, F. and Swaminathan, S. (2013) Evaluation of a Diagnostic Algorithm for Sputum Smear-Negative Pulmonary Tuberculosis in HIV-Infected Adults. Journal of Acquired Immune Deficiency Syndromes, 63, 331-338.

[35]   Walley, J., Kunutsor, S., Evans, M., Thoulass, J., Katabira, E., Muchuro, S. and Matovu, A. (2011) Validation in Uganda of the New WHO Diagnostic Algorithm for Smear-Negative Pulmonary Tuberculosis in HIV Prevalent Settings. Journal of Acquired Immune Deficiency Syndromes, 57, e93-e100.

[36]   Kang, Y.A., Kwon, S.Y., Yoon, H.I., Lee, J.H. and Lee, C.T. (2009) Role of C-Reactive Protein and Procalcitonin in Differentiation of Tuberculosis from Bacterial Community Acquired Pneumonia. The Korean Journal of Internal Medicine, 24, 337-342.

[37]   Yoon, N.B., Son, C. and Um, S.J. (2013) Role of the Neutrophil-Lymphocyte Count Ratio in the Differential Diagnosis between Pulmonary Tuberculosis and Bacterial Community-Acquired Pneumonia. Annals of Laboratory Medicine, 33, 105-110.

[38]   Baynes, R., Flax, H., Bothwell, T.H., et al. (1986a) Haematologicaland Iron Related Measurements in Active Pulmonary Tuberculosis. Scandinavian Journal of Haematology, 36, 280-287.

[39]   Corr Jr., W.P., Kyle, R. and Bowie, E.J. (1964) Hematologic Changes in Tuberculosis. The American Journal of the Medical Sciences, 248, 709-714.

[40]   Cliff, J.M., Kaufmann, S.H., McShane, H., van Helden, P. and O'Garra, A. (2015) The Human Immune Response to Tuberculosis and Its Treatment: A View from the Blood. Immunological Reviews, 264, 88-102.

[41]   O'Garra, A., Redford, P.S., McNab, F.W., Bloom, C.I., Wilkinson, R.J. and Berry, M.P. (2013) The Immune Response in Tuberculosis. Annual Review of Immunology, 31, 475-527.

[42]   Basu Roy, R., Whittaker, E. and Kampmann, B. (2012) Current Understanding of the Immune Response to Tuberculosis in Children. Current Opinion in Infectious Diseases, 25, 250-257.

[43]   Madaleno, J., Fernandes, A., Cochicho, J., Silva, N. and Carvalho, A. (2016) Immune Thrombocytopenia Associated with Pleural and Pericardial Tuberculosis: Case Report. Revista Brasileira de Hematologia e Hemoterapia, 38, 163-165.

[44]   Garg, R., Gupta, V., Mehra, S., Singh, R. and Prasad, R. (2007) Rifampicin Induced Thrombocytopenia. Indian Journal of Tuberculosis, 54, 94-96.

[45]   Yakar, F., Yildiz, N., Yakar, A. and Kılıçaslan, Z. (2013) Isoniazid- and Rifampicin-Induced Thrombocytopenia. Multidisciplinary Respiratory Medicine, 8, 13.

[46]   Renshaw, A.A. and Gould, E.W. (2013) Thrombocytosis Is Associated with Mycobacterium tuberculosis Infection and Positive Acid-Fast Stains in Granulomas. American Journal of Clinical Pathology, 139, 584-586.

[47]   Cho, S.Y., Lee, H.J., Kim, J.W. and Park, T.S. (2015) Mean Platelet Volume and Mean Platelet Volume/Platelet Count Ratio in Patients with Chronic Alcohol Consumption. Platelets, 26, 371-372.

[48]   Lee, M.Y., Kim, Y.J., Lee, H.J., Cho, S.Y. and Park, T.S. (2016) Mean Platelet Volume in Mycobacterium Tuberculosis Infection. BioMed Research International, 2016, Article ID: 7508763.

[49]   Ghare, S., Patil, M., Hote, P., Suttles, J., McClain, C., Barve, S. and Joshi-Barve, S. (2011) Ethanol Inhibits Lipid Raft-Mediated TCR Signaling and IL-2 Expression: Potential Mechanism of Alcohol-Induced Immune Suppression. Alcoholism: Clinical and Experimental Research, 35, 1435-1444.

[50]   Molina, P.E., Happel, K.I., Zhang, P., Kolls, J.K. and Nelson, S. (2010) Focus on: Alcohol and the Immune System. Alcohol Research & Health, 33, 97-108.